Pressure BioSciences Inc. PBIO Archives - Page 4 of 22

ThursdayNov 11, 2021 12:30 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialized services to the worldwide life sciences and other key industries, today announced the award of its second U.S. patent for its revolutionary Ultra Shear Technology(TM) (UST(TM)) platform. Entitled “Ultrahigh Pressure Compact Valve with Throttling Capability,” the new patent brings the company’s intellectual property (“IP”) estate to a total of seven UST patents (two in the U.S.) and 30 pressure-based patents worldwide. “The conversion of a coarser emulsion into a high-quality nanoemulsion with ultra-low droplet size is made possible by intense…

ThursdayNov 04, 2021 3:00 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroFold Platform Brings Key Capabilities Amid Strong Demand for Protein Therapeutics

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, high pressure-based instruments, platform technologies and related consumables for the worldwide life sciences, agriculture, food and beverage, and other key industries, today announced the strategic expansion of its patented BaroFold technology platform, with continued growth in services, sales and leasing. According to the update, proteins have become the biological molecule of choice in therapeutic drug development due to their high degree of specificity, proven efficacy and minimal side effects. The global protein therapeutics market is expected to reach US $233 billion by 2027. However, the…

TuesdayNov 02, 2021 12:59 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at First-of-Its-Kind Benzinga ALL ACCESS Investor Event

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and services to the worldwide life sciences and other key industries, today announced its participation in Benzinga's ALL ACCESS Investor Event. The real-time, virtual event taking place on Thursday, Nov. 4, 2021, will feature up to 12 companies in a unique, first-of-a kind format that effectively comingles part interview, part investor presentation. PBI's president and CEO Richard T. Schumacher was invited to provide a live, virtual presentation beginning at 11:20 a.m. ET on Nov. 4, where he will share recent company highlights.…

FridayOct 01, 2021 10:11 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Changes Neem Oil into Novel Nanoemulsion through Patented UST Platform

Pressure BioSciences’ (OTCQB: PBIO) patented Ultra Shear Technology(TM) (“UST”) platform has produced stable, high-quality neem oil nanoemulsions. The nanoemulsions are designed to provide safe, natural, and environmentally friendly pesticides, which can be used to mitigate agricultural losses and decrease the spread of disease by insects. These nanoemulsions combine with water and then remain suspended for months, in the process having a protective impact on ingredients that would typically deteriorate. Neem oil is a common preventative treatment for malaria, but dosing has been a challenge in the past. PBIO’s breakthrough development could provide solutions to that challenge. In addition, the nanoemulsions…

WednesdaySep 29, 2021 10:15 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Small Cap Conferences

Pressure BioSciences (OTCQB: PBIO) has announced that it will be presenting at both the Benzinga Healthcare Conference and the Emerging Growth Small Cap Conference. PBIO is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries. During the two conferences, which are real-time, interactive investor conferences, up-and-coming, innovative small-cap companies will be presenting. Representing Pressure BioSciences at the conferences will be PBIO president and CEO Richard T. Schumacher, who will present a corporate overview. The overview will include a discussion…

ThursdayAug 19, 2021 3:51 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Strong Q2 2021 Results, Eyes Highly Successful Remainder of 2021

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other key industries, today announced continued strong financial results for the second quarter ended June 30, 2021. In addition, the company provided a business update and offered guidance for the remainder of FY 2021. Among the highlights, the company reported a 127% increase in total revenue for Q2 2021 to $608,900 compared to $268,200 for Q2 2020, as well as a 178% increase in instrument sales to $337,400 compared to $121,400 for…

WednesdayAug 18, 2021 12:31 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Presenting at Emerging Growth Conference

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other key industries, has announced its participation in the Emerging Growth Conference taking place on Aug. 18, 2021. The real-time, interactive investor conference will feature 10 companies, presenting for 15-45 minutes each. PBI's president and CEO, Richard T. Schumacher, is presenting at the event, briefly expanding on the company's recent announcement that its new eco-friendly, agrochemical subsidiary (PBI Agrochem Inc.) has received over $1,000,000 in purchase orders in its first month of…

FridayAug 13, 2021 9:46 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Sees More than $1M in Orders in First Month

Pressure BioSciences (OTCQB: PBIO) announced that PBI Agrochem Inc., its new subsidiary, has received purchase orders totaling more than $1 million in its first month of operation. Agrochem provides ecofriendly agrochemical products, and the orders are for products to be delivered before year end. PBIO, a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, formed the new subsidiary in anticipation of the acquisition of a global agrochemicals products business focused on organically natural and environmentally responsible products. PBI's Ultra…

ThursdayAug 05, 2021 8:30 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Growth Plan, Goal for Remainder of 2021

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, has announced its strategic plan and goals for the second half of 2021. The company is calling the strong first half of 2021 a launch pad as it looks to an even stronger second half and a growth trajectory built on the success of multiple platform technologies. According to the announcement, the company has identified nine areas that have performed well so far this year and that…

FridayJul 30, 2021 12:49 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Business Model Expected to Generate up to $3M in Incremental Revenue

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, recently announced the development of the ultra-potent antioxidant astaxanthin (“AsX”) as an extremely fine and uniform nanoemulsion. The nanoemulsions produced by its trademarked Ultra Shear Technology(TM) (“UST”) platform encapsulate AsX in extremely small oil droplets ranging in size from 30-60 nm in diameter. “The enhanced oral bioavailability of AsX corresponding to droplet size reduction is well-established and has been published. Pressure BioSciences anticipates the use of its technology will make it possible for nutraceutical companies to exercise greater control over their…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO